000048171 000__ 01103nam\a2200361\i\4500
000048171 001__ 48171
000048171 003__ SzGeWIPO
000048171 005__ 20240708150359.0
000048171 006__ m\\\\eo\\d\\\\\\\\
000048171 007__ cr bn |||m|||a
000048171 008__ 230518s2023\\\\ilu\\\\\o\\\\\000\0\eng\d
000048171 035__ $$a(OCoLC)1373643167
000048171 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000048171 041__ $$aeng
000048171 24500 $$aThe Future of Healthcare:$$bGlaxoSmithKline v. Teva's Effect on Modern-Day Pharmaceuticals As We Know Them.
000048171 264_1 $$a[Chicago, Illinois] :$$bUIC Review of Intellectual Property Law,$$c2023
000048171 300__ $$a1 online resource (pages 256-272)
000048171 336__ $$atext$$2rdacontent
000048171 337__ $$acomputer$$2rdamedia
000048171 338__ $$aonline resource$$bcr$$2rdacarrier
000048171 4901_ $$aJohn Marshal Review of Intellectual Property Law,$$x1930-8140 ;$$vVolume 22, Issue 2, 2023, pages 256-272.
000048171 542__ $$fhttps://repository.law.uic.edu/cgi/viewcontent.cgi?article=1528&context=ripl
000048171 588__ $$aCrossref
000048171 590__ $$aPublished online: 2023
000048171 650_4 $$aCopyright Law.
000048171 650_0 $$aHealthcare$$zPharmaceuticals.
000048171 7001_ $$aMiller, Carling,$$eauthor.
000048171 7730_ $$tJohn Marshal Review of Intellectual Property Law$$wJMR
000048171 830_0 $$aJohn Marshal Review of Intellectual Property Law ;$$vVolume 22, Issue 2, 2023, pages 256-272.
000048171 85641 $$uhttps://repository.law.uic.edu/cgi/viewcontent.cgi?article=1528&context=ripl$$yonline version
000048171 904__ $$aJournal article
000048171 980__ $$aJMR